F.D.A.’s Approval of Drug for Autism Upends Review Process

Health
By Christina Jewett from NYT Health https://ift.tt/IPYeyz4
via IFTTT Intellectual Disabilities, Regulation and Deregulation of Industry, Disabilities, Autism, United States Politics and Government, Generic Brands and Products, Labeling and Labels (Product), Folic Acid, Doctors The agency revived an old treatment for cancer patients, unilaterally approving it for a subset of people with autism. Experts worry that the narrower scope will get lost in the hype.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda